HF
DARE icon

HRT Financial’s Dare Bioscience DARE Stock Holding History

HRT Financial’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47K Buy
+22,430
New +$50.1K ﹤0.01% 3787
2026
Q1 		– Sell
-10,497
Closed -$20K – 3961
2025
Q4 		$20K Buy
+10,497
New +$20.9K ﹤0.01% 2981
2022
Q4 		– Sell
-1,147
Closed -$13K – 2579
2022
Q3 		$13K Buy
+1,147
New +$15.8K ﹤0.01% 2516
2022
Q1 		– Sell
-4,032
Closed -$96K – 3241
2021
Q4 		$96K Buy
+4,032
New +$82.9K ﹤0.01% 2771

Other funds holding DARE

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

HRT Financial's DARE Position: Q2 2026 in Review

HRT Financial opened a new position in Dare Bioscience (DARE) in Q2 2026: 22,430 shares worth $47K. The stake represents ﹤0.01% of the portfolio and ranks #3787 among its holdings. This is a return to the name: HRT Financial previously reported a position in DARE as recently as Q4 2025.

HRT Financial first reported a position in DARE in Q4 2021 and has held it in 4 quarters since. The position peaked at $96K in Q4 2021. 27 funds tracked by Wall St. Rank hold DARE as of Q2 2026.

  • HRT Financial held 22,430 shares of Dare Bioscience worth $47K as of Q2 2026.
  • Dare Bioscience was a new HRT Financial position in Q2 2026.
  • Dare Bioscience made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #3787 holding.
  • HRT Financial first reported a position in Dare Bioscience in Q4 2021 and has held it in 4 quarters since.
  • HRT Financial's Dare Bioscience position peaked at $96K in Q4 2021.
  • 27 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.